Medicare considers covering expensive Alzheimer’s drug for those in clinical trials

By Jon Hamilton

January 12, 2022

NPR’s Morning Edition discussed a proposal announced on January 11, which Medicare would cover the expensive and controversial Alzheimer’s drug Aduhelm — but only for those participating in clinical trials. West Health Policy Director Sean Dickson was interviewed in the segment: “It’s not something that we as taxpayers should be paying for if it’s not actually going to help people.” 

LISTEN TO THE FULL SEGMENT ON NPR’S MORNING EDITION